Stocks to Watch: Novavax, Reata Pharmaceuticals, Rivian Automotive, FIGS, OncoSec Medical

Dow Jones

2023/03/01

By Kathryn Hardison

Novavax Inc. on Tuesday issued a going concern warning and reported fourth-quarter sales and profit that missed Wall Street views. The vaccine maker said its current cash flow looks sufficient to fund operations over the next year, though that forecast faces significant uncertainty. Shares dropped 26% in after-hours trading.

Reata Pharmaceuticals Inc.'s drug Skyclarys, or omaveloxolone, was approved by the Food and Drug Administration for treating the neurological disorder Friedreich's ataxia in adults and adolescents age 16 and older. Shares soared 189% in after-hours trading.

Rivian Automotive Inc. said it is recalling more than 12,700 of its electric vehicles and reported fourth-quarter revenue that fell short of Wall Street expectations. Shares fell 9.4% in after-hours trading.

FIGS Inc. provided guidance for mid single-digit revenue growth in 2023, compared with analysts' forecast for an 11% boost. Shares of the healthcare apparel company declined 12% in after-hours trading.

OncoSec Medical Inc. filed to withdraw a planned offering of stock and warrants. Shares jumped 47% in after-hours trading.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

February 28, 2023 18:53 ET (23:53 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2316634816"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2316634816\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2316634816?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-01 07:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2316634816","market":"us","top_or_hot":-1,"title":"Stocks to Watch: Novavax, Reata Pharmaceuticals, Rivian Automotive, FIGS, OncoSec Medical","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kathryn Hardison \n</p>\n<pre>\n \n</pre>\n<p>\n  Novavax Inc. on Tuesday issued a going concern warning and reported fourth-quarter sales and profit that missed Wall Street views. The vaccine maker said its current cash flow looks sufficient to fund operations over the next year, though that forecast faces significant uncertainty. Shares dropped 26% in after-hours trading. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/RETA\">Reata Pharmaceuticals Inc</a>.'s drug Skyclarys, or omaveloxolone, was approved by the Food and Drug Administration for treating the neurological disorder Friedreich's ataxia in adults and adolescents age 16 and older. Shares soared 189% in after-hours trading. \n</p>\n<p>\n  Rivian Automotive Inc. said it is recalling more than 12,700 of its electric vehicles and reported fourth-quarter revenue that fell short of Wall Street expectations. Shares fell 9.4% in after-hours trading. \n</p>\n<p>\n  FIGS Inc. provided guidance for mid single-digit revenue growth in 2023, compared with analysts' forecast for an 11% boost. Shares of the healthcare apparel company declined 12% in after-hours trading. \n</p>\n<p>\n  OncoSec Medical Inc. filed to withdraw a planned offering of stock and warrants. Shares jumped 47% in after-hours trading. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kathryn Hardison at kathryn.hardison@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 28, 2023 18:53 ET (23:53 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: Novavax, Reata Pharmaceuticals, Rivian Automotive, FIGS, OncoSec Medical</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: Novavax, Reata Pharmaceuticals, Rivian Automotive, FIGS, OncoSec Medical\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-03-01 07:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Kathryn Hardison \n</p>\n<pre>\n \n</pre>\n<p>\n  Novavax Inc. on Tuesday issued a going concern warning and reported fourth-quarter sales and profit that missed Wall Street views. The vaccine maker said its current cash flow looks sufficient to fund operations over the next year, though that forecast faces significant uncertainty. Shares dropped 26% in after-hours trading. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/RETA\">Reata Pharmaceuticals Inc</a>.'s drug Skyclarys, or omaveloxolone, was approved by the Food and Drug Administration for treating the neurological disorder Friedreich's ataxia in adults and adolescents age 16 and older. Shares soared 189% in after-hours trading. \n</p>\n<p>\n  Rivian Automotive Inc. said it is recalling more than 12,700 of its electric vehicles and reported fourth-quarter revenue that fell short of Wall Street expectations. Shares fell 9.4% in after-hours trading. \n</p>\n<p>\n  FIGS Inc. provided guidance for mid single-digit revenue growth in 2023, compared with analysts' forecast for an 11% boost. Shares of the healthcare apparel company declined 12% in after-hours trading. \n</p>\n<p>\n  OncoSec Medical Inc. filed to withdraw a planned offering of stock and warrants. Shares jumped 47% in after-hours trading. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Kathryn Hardison at kathryn.hardison@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 28, 2023 18:53 ET (23:53 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美国抗疫概念","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2316634816","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2316634816","pubTimestamp":1677628380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Kathryn Hardison \n\n\n \n\n\n  Novavax Inc. on Tuesday issued a going concern warning and reported fou","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","BK4588":"碎股","FIGS":"FIGS, Inc.","BK4099":"汽车制造商","BK4561":"索罗斯持仓","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","BK4539":"次新股","RETA":"Reata制药","RIVN":"Rivian Automotive, Inc.","BK4535":"淡马锡持仓","BK4139":"生物科技","NVAX":"诺瓦瓦克斯医药","BK4555":"新能源车","BK4007":"制药"},"translate_title":"值得关注的股票：Novavax、Reata Pharmaceuticals、Rivian汽车、无花果、OncoSec Medical","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONCS":1,"NVAX":1,"FIGS":1,"RETA":1,"RIVN":1},"content_text":"By Kathryn Hardison \n\n\n \n\n\n  Novavax Inc. on Tuesday issued a going concern warning and reported fourth-quarter sales and profit that missed Wall Street views. The vaccine maker said its current cash flow looks sufficient to fund operations over the next year, though that forecast faces significant uncertainty. Shares dropped 26% in after-hours trading. \n\n\nReata Pharmaceuticals Inc.'s drug Skyclarys, or omaveloxolone, was approved by the Food and Drug Administration for treating the neurological disorder Friedreich's ataxia in adults and adolescents age 16 and older. Shares soared 189% in after-hours trading. \n\n\n  Rivian Automotive Inc. said it is recalling more than 12,700 of its electric vehicles and reported fourth-quarter revenue that fell short of Wall Street expectations. Shares fell 9.4% in after-hours trading. \n\n\n  FIGS Inc. provided guidance for mid single-digit revenue growth in 2023, compared with analysts' forecast for an 11% boost. Shares of the healthcare apparel company declined 12% in after-hours trading. \n\n\n  OncoSec Medical Inc. filed to withdraw a planned offering of stock and warrants. Shares jumped 47% in after-hours trading. \n\n\n \n\n\n  Write to Kathryn Hardison at kathryn.hardison@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2023 18:53 ET (23:53 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}